Two CTCL Trails on Partial Hold After Patient Death
source: shutterstock.com

Two CTCL Trails on Partial Hold After Patient Death

  The two trials evaluating lacutamab, an investigational therapy developed to treat T-cell lymphomas, were put on partial hold by the FDA. The patient died of hemophagocytic lymphohistiocytosis, which is…

Continue Reading Two CTCL Trails on Partial Hold After Patient Death
A Recent Discovery Could Make Cancer Treatments More Effective
ColiN00B / Pixabay

A Recent Discovery Could Make Cancer Treatments More Effective

According to a story from news-medical.net, scientists may have made a significant breakthrough discovery that could make cancer treatment more effective. The discovery involves a new method that breaks through…

Continue Reading A Recent Discovery Could Make Cancer Treatments More Effective
First Treatment for Hemophagocytic Lymphohistiocytosis is Approved by the FDA
frolicsomepl / Pixabay

First Treatment for Hemophagocytic Lymphohistiocytosis is Approved by the FDA

According to a story from BioSpace, the biopharmaceutical company Sobi and the biotechnology company NovImmune SA have recently announced that the US Food and Drug Administration (FDA) has approved Gamifant,…

Continue Reading First Treatment for Hemophagocytic Lymphohistiocytosis is Approved by the FDA